Hemophilia marketing tactics raise questions as market heats up

Carly Helfand

While there are plenty of drugs for , new patients can be few and far between. To build their share, some drugmakers and specialty pharmacies have begun hiring patients and their families to convince others to make a treatment switch–a practice that toes the ethical line and makes some hemophiliacs uncomfortable.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS